ZDHHC9 and myeloid neoplasm: Ren and colleagues have discovered a role of the CBL/JAK2/RAB27B/ZDHHC9 signaling axis in regulating NRAS trafficking to the plasma membrane for activation by palmitoylation in myeloid malignancies (14) (Figure 1).